Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from BSX

Is Boston Scientific Stock Outperforming the S&P 500?

Boston Scientific recently reached an all-time high, outperforming the S&P 500 Index, with Wall Street analysts remaining bullish about the stock’s prospects.

Barchart

Boston Scientific Stock: Is Wall Street Bullish or Bearish?

Boston Scientific has significantly outperformed the broader market YTD, and Wall Street analysts are still bullish about the stock’s prospects.

Barchart

Boston Scientific Surges To A Record On Its 'Impressive' First-Quarter Guidance

Boston Scientific's first-quarter sales guidance is "impressive," an analyst said Wednesday as BSX stock hit a record high.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Stryker, Boston Scientific Score Earnings Beats, Extend Breakouts

Shares of Stryker, Boston Scientific jumped early Wednesday after healthy earnings beats and price target hikes from analysts.

Investors Business Daily

Smith & Nephew (SNN) vs. Boston Scientific (BSX): Buy or Sell as These Medical Stocks Gear up for Quarterly Earnings?

The medical devices and equipment industry is primed to make significant strides toward growth this year, a surge propelled by increasing incidences of chronic diseases and the emphasis on early detection and treatment, coupled with leaps in technological development. Given this backdrop, let’s compare medical device stocks Boston Scientific (BSX)…

StockNews.com

Boston Scientific, Edwards Lifesciences Tumble As Guidance 'Noise' Slams The Latter

Boston Scientific beat third-quarter expectations, but Edwards Lifesciences' metrics were just in line. Shares of both tumbled.

Investors Business Daily

Boston Scientific Offers Bullish Guidance And Briefly Breaks Out

Boston Scientific kicked off its Investor Day on Wednesday, a day after announcing its Relievant buyout, and BSX stock jumped.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Boston Scientific Surges As It Looks To Enter A Market Worth Nearly $8 Billion

Boston Scientific is likely to win FDA approval for a new method of treating abnormal heartbeats. BSX stock surged on its Phase 3 win.

Investors Business Daily

BSX Stock Near Buy Point As Boston Scientific Beats On Earnings, Raises Outlook

BSX stock rose toward a buy point after Boston Scientific earnings rose 20% as hospital procedures stabilize after the Covid pandemic.

Investors Business Daily

4 Hyper-Growth Stocks That Could Soar

Coupled with the macroeconomic headwinds, the U.S. debt default crisis and consequent recessionary fears have triggered market volatility. Against this backdrop, quality growth stocks Boston Scientific (BSX), Cardinal Health (CAH), Cidara Therapeutics (CDTX), and Geospace Technologies (GEOS) could be solid buys now. Read on….

StockNews.com

Boston Scientific Yo-Yoes As Medical Recovery Drives Quarterly Beat

Boston Scientific reported better-than-expected first-quarter growth on Tuesday, but BSX stock yo-yoed on the results.

Investors Business Daily

Thermo Fisher Pops On Its Bullish Outlook As Boston Scientific Gains On Its In-Line Report

Thermo Fisher easily beat quarterly projections, while Boston Scientific was in line. TMO stock popped Wednesday while BSX stock also rose.

Investors Business Daily

How Mixed Earnings Helped Boston Scientific Creep Toward A Breakout

Boston Scientific posted a mixed third quarter Wednesday, though sales of one of its key products likely grew more than 30%. BSX stock rose.

Investors Business Daily

Boston Scientific Stock Comes In Hot; Cardiology Business Is 'On Fire'

Boston Scientific's cardiology division was "on fire" in the second quarter, an analyst said Wednesday as BSX stock surged on its beat.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Here's How Much You Would Have Made Owning Boston Scientific Stock In The Last 10 Years

Boston Scientific (NYSE:BSX) has outperformed the market over the past 10 years by 9.66% on an annualized basis producing an average annual return of 20.68%. Currently, Boston Scientific has a market capitalization of $54.31 billion.

Benzinga

Boston Scientific Buys Substantial Stake In Korean MedTech Player

Boston Scientific Corporation (NYSE:BSX) has agreed to purchase Synergy Innovation Co Ltd's majority stake (~64%) of M.I.Tech Co Ltd, a publicly-traded Korean manufacturer, and distributor of medical devices for endoscopic and urologic procedures. The deal is valued at KRW 14,500 per share, representing KRW 291.2 billion or approximately $230 million. M.I.Tech offers HANAROSTENT technology, a…

Benzinga

Here's How Much You Would Have Made Owning Boston Scientific Stock In The Last 10 Years

Boston Scientific (NYSE:BSX) has outperformed the market over the past 10 years by 9.09% on an annualized basis producing an average annual return of 20.41%. Currently, Boston Scientific has a market capitalization of $53.12 billion.

Benzinga

If You Invested $1000 In Boston Scientific 10 Years Ago, Here's How Much You Would Have Today

Boston Scientific (NYSE:BSX) has outperformed the market over the past 10 years by 9.68% on an annualized basis producing an average annual return of 21.79%. Currently, Boston Scientific has a market capitalization of $58.91 billion.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Belo Sun Receives Interim Suspension Order Related To Volta Grande Project

Belo Sun Mining Corp. (TSX: BSX) (OTC: BSXGF)

Benzinga

Boston Scientific Jumps On Upbeat Q2, FY22 Guidance

Boston Scientific Corp (NYSE:BSX) generated net sales of $3.026 billion in Q1 FY22, beating the Wall Street estimate of $2.95 billion. Sales increased 10% Y/Y on a reported basis, 12.6% on an operational basis, and 9.7% on an organic basis, better than the management estimate of approximately 5% - 8%. The Company achieved…

Investors Business Daily

Boston Scientific Ekes Out A Narrow First-Quarter Beat, Offers So-So Sales Guide

Boston Scientific eked out a narrow first-quarter beat that also topped industry trends, an analyst said Wednesday as BSX stock popped.

Investors Business Daily

Earnings Beat Views, But Boston Scientific Drops On Lackluster Guidance

Boston Scientific topped fourth-quarter expectations, but guidance for 2022 was lighter than expected and BSX stock tumbled.

Benzinga

Why Is Boston Scientific Stock Trading Lower Premarket Today?

Boston Scientific Corp (NYSE: BSX) generated

1 2

People

Sristi Suman JayaswalThe

216 stories

Vijay Kumar

131 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Medical Devices Equipment

Boston Scientific Corporation

10 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.